ISPC vs PSA · rev $9.3M vs rev $4.82B
iSpecimen Inc (ISPC) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
PSA (PSA) common stock.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
ISPC currently screens at market cap $4.4M. PSA currently screens at market cap $0.
Not investment advice. Open the ISPC and PSA stock pages for the full models.
Not investment advice.